EUCTR2005-003187-32-DK进行中（未招募）不适用
A phase II study of etoposide, oxaliplatin and capecitabine in patients with advanced hepatocellular carcinoma
Department of Oncology, Rigshospitalet0 个研究点目标入组 39 人开始时间: 2005年12月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 39
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Advanced hepatocellular carcinoma
- •Performance status 0-2
- •Life expectancy > 12 weeks
- •Adequate liver, renal and cardiac function
- •Negative pregnancy test for fertile women
- •Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Prior chemotherapy within last 4 weeks
- •Prior radiotherapy within last 4 weeks
- •Prior immunotherapy within last 4 weeks
- •Concurrent experimental therapy
- •Allergy to the IMPs
- •Known PDP defiency
- •Other malignacy within last 5 years
研究者
相似试验
已完成
不适用
A Phase II Study of Cisplatin, Etoposide and Concurrent Thoracic Irradiation Followed by Irinotecan and Cisplatin in Patients with Limited Small-Cell Lung CancerD-SCLCJPRN-C000000109West Japan Oncology Group60
招募中
2 期
A phase II study of atezolizumab plus chemotherapy for elderly patients with ED-SCLCSmall cell lung cancerJPRN-jRCTs041210002Takahashi Toshiaki40
进行中（未招募）
2 期
A phase II study of carboplatin and etopside plus durvalumab for previously-untreated extensive-stage small-cell lung cancer (ES-ECLC) patients with poor performance status (PS) - NEJ045Aextensive disease small cell lung cancerJPRN-jRCTs031200319Watanabe Satoshi56
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or WithoutTrilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung Cancerntreated Extensive-Stage Small Cell Lung CancerMedDRA version: 21.1Level: PTClassification code 10041068Term: Small cell lung cancer extensive stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-000358-20-LVG1 Therapeutics100
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or WithoutTrilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung CancerEUCTR2017-000358-20-BGG1 Therapeutics100